BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 33940597)

  • 1. Aspirin and antiplatelet treatments in cancer.
    Tao DL; Tassi Yunga S; Williams CD; McCarty OJT
    Blood; 2021 Jun; 137(23):3201-3211. PubMed ID: 33940597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents.
    Xu XR; Yousef GM; Ni H
    Blood; 2018 Apr; 131(16):1777-1789. PubMed ID: 29519806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug.
    Mitrugno A; Sylman JL; Rigg RA; Tassi Yunga S; Shatzel JJ; Williams CD; McCarty OJT
    Platelets; 2018 Dec; 29(8):773-778. PubMed ID: 29265902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin, platelets, and cancer: The point of view of the internist.
    Santilli F; Boccatonda A; Davì G
    Eur J Intern Med; 2016 Oct; 34():11-20. PubMed ID: 27344083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer.
    Roop RP; Naughton MJ; Van Poznak C; Schneider JG; Lammers PE; Pluard TJ; Johnson F; Eby CS; Weilbaecher KN
    Clin Breast Cancer; 2013 Dec; 13(6):409-15. PubMed ID: 24267729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
    Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
    Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry.
    Li N; Hu H; Hjemdahl P
    Thromb Res; 2003; 111(3):165-70. PubMed ID: 14678815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of aspirin and ticagrelor on Toll-like receptor (TLR)-mediated platelet activation: results of a randomized, cross-over trial.
    Hally KE; La Flamme AC; Harding SA; Larsen PD
    Platelets; 2019; 30(5):599-607. PubMed ID: 29869943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The platelet contribution to cancer progression.
    Bambace NM; Holmes CE
    J Thromb Haemost; 2011 Feb; 9(2):237-49. PubMed ID: 21040448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.
    Contursi A; Sacco A; Grande R; Dovizio M; Patrignani P
    Cell Mol Life Sci; 2017 Oct; 74(19):3491-3507. PubMed ID: 28488110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
    Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
    Front Immunol; 2021; 12():807600. PubMed ID: 34987523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous assay of activated platelet count and platelet-activating capacity by P-selectin detection using K2-EDTA-treated whole blood for antiplatelet agents.
    Okano K; Araki M; Mimura Y; Nogaki H; Ichihara K
    Int J Lab Hematol; 2012 Dec; 34(6):621-9. PubMed ID: 22862794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug Resistance Protein 4 (MRP4/ABCC4): A Suspected Efflux Transporter for Human's Platelet Activation.
    Angelis I; Moussis V; Tsoukatos DC; Tsikaris V
    Protein Pept Lett; 2021; 28(9):983-995. PubMed ID: 33964863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin, platelet inhibition and cancer prevention.
    Patrignani P; Patrono C
    Platelets; 2018 Dec; 29(8):779-785. PubMed ID: 29985750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis.
    Rovati G; Contursi A; Bruno A; Tacconelli S; Ballerini P; Patrignani P
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study.
    De Luca G; Secco GG; Iorio S; Verdoia M; Bellomo G; Marino P
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):756-9. PubMed ID: 23135381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
    Schrottmaier WC; Kral JB; Badrnya S; Assinger A
    Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.